1826-28-4 Usage
Description
Phenyl 2-pyridyl ketoxime is a slightly pink crystalline powder that is known for its complexation properties with various transition and heavy metal ions, such as Co2+, Ni2+, Zn2+, Pb2+, Fe2+, Fe3+, Cr3+, and La2+. This characteristic makes it a valuable compound in the synthesis of metal complexes and clusters.
Uses
Used in Chemical Synthesis:
Phenyl 2-pyridyl ketoxime is used as a precursor in the preparation of inverse-9-metallacrown-3, trinuclear clusters. Its ability to complex with metal ions allows for the formation of stable and unique metal complexes with potential applications in various fields.
Used in Coordination Chemistry:
In coordination chemistry, Phenyl 2-pyridyl ketoxime is used as a ligand for the formation of metal complexes. Its complexation reaction with metal ions has been studied potentiometrically, providing insights into the stability and properties of the resulting complexes.
Used in Analytical Chemistry:
The complexation properties of Phenyl 2-pyridyl ketoxime can be utilized in analytical chemistry for the selective detection and quantification of metal ions. Its ability to form stable complexes with specific metal ions can be exploited in the development of sensors and analytical methods.
Used in Material Science:
The metal complexes formed using Phenyl 2-pyridyl ketoxime can be employed in material science for the development of new materials with unique properties. These materials can be used in various applications, such as catalysts, electronic devices, and advanced materials with tailored properties.
Purification Methods
The E-isomer crystallises from EtOH (charcoal). It isomerizes to the Z-isomer on melting or in boiling o-xylene, and crystallises from EtOH or cyclohexanol with m 166-168o. [Beilstein 21 H 330, 21 III/IV 4120, 21/8 V 568.]
Check Digit Verification of cas no
The CAS Registry Mumber 1826-28-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,2 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1826-28:
(6*1)+(5*8)+(4*2)+(3*6)+(2*2)+(1*8)=84
84 % 10 = 4
So 1826-28-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H10N2O/c15-14-12(10-6-2-1-3-7-10)11-8-4-5-9-13-11/h1-9,15H/b14-12-
1826-28-4Relevant articles and documents
A Pentanuclear Cobalt Complex with two [CoII(CH3O)3]– Units Wrapping a Triangular [CoIII3O]7+ Core: Synthesis, Structure, and Magnetic Properties
Yang, Hua,Li, Ruiling,Li, Dacheng,Zeng, Suyuan,Dou, Jianmin
, p. 585 - 589 (2018)
The reaction of Hppko (Hppko = phenyl 2-pyridyl ketone oxime) and CoCl2·6H2O in the CH3OH solvent with the presence of triethylamine (NEt3) at room temperature and the exposure to air resulted in the formation of a new pentanuclear, mixed-valence cobalt complex with the molecular formula [{CoII(CH3O)3}2{CoIII3(μ3-O)(ppko)3}Cl2]. X-ray single crystal analysis displays a trigonal bipyramid configuration with the terminal two CoII ions wrapping an triangle [CoIII3O]7+ core. The intermolecular C–H···O and C–H···Cl interactions form a 2D network framework. The analysis of magnetic susceptibility revealed the dominant antiferromagnetic interactions and strong orbital contribution of CoII ions.
Tertiary α-diarylmethylamines derived from diarylketimines and organomagnesium reagents
Desmarchelier, Alaric,Ortiz, Pablo,Harutyunyan, Syuzanna R.
supporting information, p. 703 - 706 (2015/01/09)
Organomagnesium reagents enable swift and versatile derivatisation of diarylimines to the corresponding α-substituted diarylmethylamines in excellent yields, through fast and clean reactions. Where it occurs, 1,2-reduction can be circumvented using readily accessible dialkylmagnesium reagents. This journal is
Synthesis, docking study and β-Adrenoceptor activity of some new oxime ether derivatives
Ghabbour, Hazem A.,El-Bendary, Eman R.,El-Ashmawy, Mahmoud B.,El-Kerdawy, Mohamed M.
, p. 3417 - 3435 (2014/04/17)
A new series of oxime ethers 4a-z was designed and synthesized to test the blocking activity against β1 and β2-Adrenergic receptors. Docking of these ether derivatives into the active site of the identified 3D structures of β1 and β2-Adrenergic receptors
